Patents by Inventor Shin Ae Yi

Shin Ae Yi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYOPHILIZED FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A
    Publication number: 20250099558
    Abstract: The present invention relates to a lyophilized formulation including a fusion protein of ?-galactosidase A and a preparation method thereof, wherein the lyophilized formulation not only has storage stability by including a composition providing structural stability to a fusion protein of ?-galactosidase A, but also has excellent stability although the fusion protein is contained at a high concentration.
    Type: Application
    Filed: March 10, 2023
    Publication date: March 27, 2025
    Inventors: Miroo KIM, Miri YOO, Jae Woon SON, Da-eui PARK, Shin-Ae YI, Jin Young KIM, Jun Sub PARK, Doo Seo JANG, Sung Hee HONG, Sang Yun KIM
  • Anti-PD-L1 antibody and use thereof
    Patent number: 11407834
    Abstract: Disclosed are an anti-PD-L1 antibody or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, a pharmaceutical composition for preventing or treating cancer containing the same, and a composition for co-administration with an antibody other than an antibody binding to PD-L1, containing the same.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: August 9, 2022
    Assignee: PHARMABCINE INC.
    Inventors: Sungho Ahn, Miju Park, Eun Hee Lee, Shin Ae Yi, Sang Soon Byun, Hyuk Joon Lee, Do-Yun Kim, Jinsang Yoo, Keunhee Oh, Weon Sup Lee, Jin-San Yoo
  • ANTI-PD-L1 ANTIBODY AND USE THEREOF
    Publication number: 20210054078
    Abstract: Disclosed are an anti-PD-L1 antibody or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, a pharmaceutical composition for preventing or treating cancer containing the same, and a composition for co-administration with an antibody other than an antibody binding to PD-L1, containing the same.
    Type: Application
    Filed: December 27, 2018
    Publication date: February 25, 2021
    Inventors: Sungho Ahn, Miju Park, Eun Hee Lee, Shin Ae Yi, Sang Soon Byun, Hyuk Joon Lee, Do-Yun Kim, Jinsang Yoo, Keunhee Oh, Weon Sup Lee, Jin-San Yoo